Literature DB >> 33933316

Differences and disparities in seasonal influenza vaccine, acceptance, adverse reactions, and coverage by age, sex, gender, and race.

Aniket Kini1, Rosemary Morgan2, Helen Kuo2, Patrick Shea3, Janna Shapiro2, Sean X Leng4, Andrew Pekosz3, Sabra L Klein5.   

Abstract

BACKGROUND: Influenza is a significant threat to public health worldwide. Despite the widespread availability of effective and generally safe vaccines, the acceptance and coverage of influenza vaccines are significantly lower than recommended. Sociodemographic variables are known to be potential predictors of differential influenza vaccine uptake and outcomes.
OBJECTIVES: This review aims to (1) identify how sociodemographic characteristics such as age, sex, gender, and race may influence seasonal influenza vaccine acceptance and coverage; and (2) evaluate the role of these sociodemographic characteristics in differential adverse reactions among vaccinated individuals.
METHODS: PubMed was used as the database to search for published literature in three thematic areas related to the seasonal influenza vaccine - vaccine acceptance, adverse reactions, and vaccine coverage.
RESULTS: A total of 3249 articles published between 2010 and 2020 were screened and reviewed, of which 39 studies were included in this literature review. By the three thematic areas, 17 studies assessed vaccine acceptance, 8 studies focused on adverse reactions, and 14 examined coverage of the seasonal influenza vaccine. There were also two studies that focused on more than one of the areas of interest.
CONCLUSION: Each of the four sociodemographic predictors - age, sex, race, and gender - were found to significantly influence vaccine acceptance, receipt and outcomes in this review.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Influenza; Racial differences; Safety; Sex differences; Vaccine coverage; Vaccine hesitancy

Mesh:

Substances:

Year:  2021        PMID: 33933316      PMCID: PMC8551304          DOI: 10.1016/j.vaccine.2021.04.013

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  Side Effects of COVID-19 Inactivated Virus vs. Adenoviral Vector Vaccines: Experience of Algerian Healthcare Workers.

Authors:  Mohamed Lounis; Mohammed Amir Rais; Djihad Bencherit; Hani Amir Aouissi; Adda Oudjedi; Jitka Klugarová; Andrea Pokorná; Miloslav Klugar; Abanoub Riad
Journal:  Front Public Health       Date:  2022-05-16

2.  COVID-19 vaccine hesitancy in eight European countries: Prevalence, determinants, and heterogeneity.

Authors:  Janina I Steinert; Henrike Sternberg; Hannah Prince; Barbara Fasolo; Matteo M Galizzi; Tim Büthe; Giuseppe A Veltri
Journal:  Sci Adv       Date:  2022-04-27       Impact factor: 14.957

3.  Time Trends (2012-2020), Sex Differences and Predictors for Influenza Vaccination Uptake among Individuals with Chronic Obstructive Pulmonary Disease in Spain.

Authors:  Marta Fuentes-Alonso; Rodrigo Jimenez-Garcia; Ana Lopez-de-Andres; Jose J Zamorano-Leon; David Carabantes-Alarcon; Isabel Jimenez-Trujillo; Sara Sanz-Rojo; Javier de Miguel-Diez
Journal:  J Clin Med       Date:  2022-03-04       Impact factor: 4.964

4.  Influenza Vaccination Coverage among Multiple Sclerosis Patients: Evolution over Time and Associated Factors.

Authors:  Ignacio Hernández-García; Moisés Garcés-Redondo; Joana Rodríguez-Montolio; Irantzu Bengoa-Urrengoechea; Judit Espinosa-Rueda; Carlos Aibar-Remón
Journal:  Vaccines (Basel)       Date:  2022-07-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.